To determine enzalutamide responsiveness is related to androgen synthesis in bone tumors, we evaluated the expression of key enzymes in androgen synthesis, AKR1C3, HSD3B1 and HSD3B2, in bone tumors. The gene discussed is HSD3B2; the disease is bone neoplasm.